Many membrane proteins are subjected to limited proteolyses at their juxtamembrane regions, processes referred to as ectodomain shedding. Shedding ectodomains of membrane-bound ligands results in activation of downstream signaling pathways, whereas shedding those of cell adhesion molecules causes loss of cell-cell contacts. Secreted proteomics (secretomics) using high-resolution mass spectrometry would be strong tools for both comprehensive identification and quantitative measurement of membrane proteins that undergo ectodomain shedding. In this study, to elucidate the ectodomain shedding events that occur during neuronal differentiation, we establish a strategy for quantitative secretomics of glycoproteins released from differentiating neuroblastoma cells into culture medium with or without GM6001, a broadspectrum metalloprotease inhibitor. Considering that most of transmembrane and secreted proteins are N-glycosylated, we include a process of N-glycosylated peptides enrichment as well as isotope tagging in our secretomics workflow. Our results show that differentiating N1E-115 neurons secrete numerous glycosylated polypeptides in metalloprotease-dependent manners. They are derived from cell adhesion molecules such as NCAM1, CADM1, L1CAM, various transporters and receptor proteins. These results show the landscape of ectodomain shedding and other secretory events in differentiating neurons and/or during axon elongation, which should help elucidate the mechanism of neurogenesis and the pathogenesis of neurological disorders.
Introduction
Ectodomain shedding refers to the process by which many transmembrane proteins are subjected to limited proteolysis at their juxtamembrane regions. Ectodomain shedding of transmembrane proteins such as ErbB ligands results in the release of their extracellular domains from the lipid bilayer and the activation of downstream signaling cascades, whereas ectodomain shedding of cell adhesion molecules such as cadherins or selectin ligands causes loss of cell-cell contacts. In most cases, shedding triggers another proteolysis at the intramembranous region, which results in a release of the intracellular region. For example, these sequential proteolyses of Notch induce translocation of its intracellular domain to the nucleus to activate transcription critical for cellular differentiation. Ectodomain shedding thus mediates development, regeneration and diseases by modulating various cellular behaviors such as proliferation, migration, differentiation, death, tissue remodeling and so on (Huovila et al. 2005; Reiss & Saftig 2009; Weber & Saftig 2012) .
Several families of proteases are involved in the ectodomain shedding and are called as sheddases or secretases. Members of a disintegrin and metalloproteases (ADAMs) constitute one of main sheddase families. For instance, ADAM10 (Kuzbanian) is involved in the ectodomain shedding of Notch when it is engaged with its ligand (Bozkulak & Weinmaster 2009; van Tetering et al. 2009; Saftig & Lichtenthaler 2015) and that of Neuroligin in activity-dependent manners (Suzuki et al. 2012) . ADAM17 (TACE) sheds ectodomains of various transmembrane proteins including ErbB ligands in response to phorbol ester (PMA) (Huovila et al. 2005) , whereas ADAM19 (Meltrin beta) constitutively sheds the ectodomain of Neuregulin 1, one of major ErbB ligands (Shirakabe et al. 2001) . However, these studies have not clarified what kind of ectodomain shedding as a whole occurs in various biological processes such as cell proliferation and differentiation. To solve this question, we need to establish sensitive and reliable methods to systematically screen transmembrane proteins that are shed in different contexts rather than examining one to one relationship between an enzyme and a substrate in certain cells or tissues. As an attempt to establish such methods, we carried out secreted proteome (secretome) analyses of differentiating neuronal cells and asked whether the analyses can identify transmembrane proteins released into the culture medium through metalloprotease-mediated ectodomain shedding.
Results
Quantitative proteomics identified glycoproteins released from differentiating neurons in a metalloprotease-dependent manner
To obtain a landscape of metalloprotease-dependent ectodomain shedding during neuronal differentiation, we conducted stable isotope-based quantitative proteome analysis by high-resolution liquid chromatography-tandem mass spectrometry (LC-MS/MS). We selected neuroblastoma N1E-115 cells because they differentiate into neurons by removal of serum (Kurisaki et al. 2002) and are suitable for purification of secreted proteins. Cultured media of differentiating N1E-115 cells with or without GM6001, a broadspectrum metalloprotease inhibitor, were collected for the analysis (Fig. 1A) . Considering that most of membrane proteins and extracellular proteins are N-glycosylated (Apweiler et al. 1999) , we used an enrichment step for N-glycosylated peptides (Zhang et al. 2003; Nagano et al. 2011 ) based on hydrazide chemistry, followed by N-Glycosidase F (PNGase F) treatment in H 2 18 O for releasing de-glycosylated peptides labeled with 18 O (Fig. 1B) according to the isotope-coded glycosylation site-specific tagging (IGOT) approach (Kaji et al. 2003) . The eluents were labeled by reductive dimethylation of amino groups with distinct stable isotopes (Hsu et al. 2003) using light (( 12 CH 3 ) 2 N-) and heavy (( 13 CD 2 H) 2 N-) tags for DMSO-and GM6001-treated samples, respectively. The labeled samples were combined and analyzed by LC-MS/MS. The sample preparation was carried out in duplicate, and the duplicate LC-MS/MS measurement was carried out for each sample (n = 4 in total). Overall, 2053 nonredundant peptides derived from 765 proteins were identified from four data sets by Mascot search against a mouse-bovine concatenated (A) (B) Figure 1 Schematic representation of proteomic screening of N-glycoproteins released from differentiating neurons in metalloprotease-dependent manners. A-B, A scheme of proteomic screening method for glycoproteins released into the conditioned medium in metalloprotease-dependent manners. Proteins released into the conditioned medium are digested, and N-glycosylated peptides were enriched using hydrazide gel, isotopically labeled and analyzed by LC-MS/MS. database at false discovery rate below 1% both at peptide and protein levels. Among the 2053 nonredundant peptides identified, 1571 peptides were assigned to murine proteins. Additionally, all precursor ions of the identified peptides in mass spectra were manually inspected to confirm the 18 O-incorporation by IGOT reaction, indicating these peptides were N-glycosylated before IGOT reaction (Tables S1-S4 in Supporting information). As a result, 927 N-glycopeptides derived from 328 proteins were obtained. For quantitative analysis, we only accepted 274 glycopeptides with relative standard deviation (RSD) of H/L ratios below 20% (Table S5 in Supporting information), resulting in 166 glycoproteins (Table S6 in Supporting information). Among them, 18 glycoproteins showed a prominent decrease (more than 50%) in the release into the culture medium by the treatment with GM6001, which included previously reported shedding targets, such as neural cell adhesion molecule 1 (NCAM1), cell adhesion molecule 1 (CADM1) and vesicular integral membrane protein 36 (VIP36) (Hinkle et al. 2006; Shirakabe et al. 2011; Nagara et al. 2012) , supporting the validity of our system ( Fig. 2A and Table 1 ). Interestingly, not only membrane-bound ligands or cell adhesion proteins but also some transporters and receptors, such as zinc transporter ZIP6, transferrin receptor protein 1 (TFRC), proto-oncogene tyrosine-protein kinase receptor Ret and ALK tyrosine kinase receptor, were decreased upon GM6001 treatment ( Fig. 2A) . Thus, differentiating N1E-115 neuronal cells release various glycosylated polypeptides derived from transmembrane or membrane-anchored glycoproteins in metalloprotease-dependent manners. To examine whether any types of glycoproteins are released preferentially in GM6001-dependent manners, we analyzed gene ontology of all the quantified glycoproteins using the Database for Annotation, Visualization and Integrated Discovery (DAVID) (v.6.8, https://david-d.ncifcrf. gov/). As shown in Fig. 2B , the result shows that most of GM6001-sensitive glycoproteins are indeed transmembrane ones. When these glycoproteins were annotated on biological processes and evaluated against all quantified proteins, glycoproteins involved in the nervous system development are enriched significantly (P < 0.05) ( Table S7 in Supporting information). An additional enrichment analysis on the terms annotated by InterPro (https://www.ebi.ac.uk/ interpro/) showed that glycoproteins with three types of immunoglobulin (Ig)-like domains show significantly higher hit rates than other glycoproteins as GM6001-sensitive ones (P < 0.05) ( Table S8 in Supporting information). However, the release of amyloid precursor protein (APP) is insensitive to GM6001; the release of two transmembrane proteins, erythrocyte band 7 integral membrane protein (stomatin, STOM) and sialomucin core protein 24 (CD164), is increased by GM6001 ( Fig. 2A ).
Ectodomain shedding of L1CAM
Interestingly, the sensitivity to GM6001 is quite different from one glycoprotein to another ( Fig. 2A) . Because the secretion of L1CAM is much less sensitive to GM6001 than other cell adhesion molecules such as NCAM and CADM1, we examined whether L1CAM is certainly shed by metalloproteases. N-terminally HA-tagged L1CAM was expressed in N1E-115 cells, and the cell extracts and culture media were prepared and subjected to Western blotting using an anti-HA antibody. The ectodomain shedding of overexpressed L1CAM in differentiating N1E-115 cells was inhibited by GM6001 but not by GM6001-negative control (NC), a structurally similar derivative of GM6001 without metalloprotease inhibitor activity (Fig. S1A , B in Supporting information). In addition, PMA-stimulated shedding of L1CAM was also effectively inhibited by GM6001 (Fig. S1C , D in Supporting information). These results suggest that exogenous L1CAM is mainly shed by metalloproteases.
Discussion
In this study, we developed a systematic method for comprehensive identification of glycoproteins released by the ectodomain shedding and/or other secretory processes. We obtained a fundamental data on glycoproteins that are released into the extracellular space in metalloprotease-dependent manners in differentiating neurons as an experimental model. These glycoproteins include transmembrane proteins, which are previously reported to undergo metalloproteasedependent ectodomain shedding, such as L1CAM, NCAM1, CADM1 and VIP36 (Hinkle et al. 2006; Shirakabe et al. 2011; Nagara et al. 2012; Saftig & Lichtenthaler 2015) , indicating high accuracy and high reliability of this method. We found that transmembrane proteins release their ectodomains with different sensitivities to GM6001 among each other. Our quantitative analysis showed relatively low contribution of GM6001-sensitive metalloproteases in the release of L1CAM ectodomain in differentiating N1E-115 cells. As ADAM10 and ADAM17 are involved in the constitutive and PMA-stimulated ectodomain shedding of L1CAM, respectively (Maretzky et al. 2005; Riedle et al. 2009 ), these ADAMs should be mainly responsible for the GM6001-sensitive release of L1CAM in N1E-115 cells. However, the fact that a GM6001-insensitive protease, beta-site APP converting enzyme 1 (BACE1), sheds the ectodomain of L1CAM in neurons in the absence of ADAM10 thus suggests alternative ectodomain shedding of L1CAM by ADAM10 and BACE1 (Zhou et al. 2012; Saftig & Lichtenthaler 2015) . Taken together, the difference in sensitivity to GM6001 might reflect the difference of responsible proteases for each membrane protein in differentiating N1E-115 cells. Interestingly, exogenously expressed L1CAM is much sensitive to GM6001 compared to endogenous L1CAM. Such differences could be attributed to the differences in intracellular distribution caused by the differences of (Vassar et al. 2014) , our results raise a possibility that inhibition of metalloproteases enhances the accessibility of APP to BACEs. In near future, our proteomic approach will also show the release of proteins sensitive to other protease inhibitors such as those of BACEs and would tell us how different proteases participate in the ectodomain shedding of APP more clearly. In contrast, the release of two transmembrane proteins, STOM and CD164, is increased by GM6001. CD164 is a member of sialomucin proteins, and another sialomucin protein, CD43, is likely shed by Cathepsin G, a serine protease (Mambole et al. 2008) . Thus, proteases other than metalloproteases might be responsible for their proteolyses. The release of soluble proteins including extracellular matrix proteins, fibronectin, laminin, and insulin-like growth factorbinding protein 7 (IGFBP7) is GM6001-insensitive, consistent with their metalloprotease-independent release.
Although accurate cleavage sites are unpredictable with our method, we can make a rough assumption of cleavage regions of glycoproteins from the secretome data when the cleavage sites are located within a region containing many N-glycosylation sites. , suggesting that ectodomain shedding likely occurs at highly glycosylated region of L1CAM. It is noteworthy that proximal O-glycosylation affects ADAM-mediated cleavage (Goth et al. 2015) . How glycosylation affects the shedding reactions is one of key questions on ectodomain shedding.
Our analyses detected GM6001-sensitive GPIanchored proteins such as contactin-3 and GDNF family receptor alpha-1 (GFRA1). Several mechanisms are likely involved in the release of GPIanchored proteins. For example, prion protein, one of major GPI-anchored proteins, is known to be shed by ADAM10 and ADAM17 (Altmeppen et al. 2011; Glatzel et al. 2015; Saftig & Lichtenthaler 2015) . However, GDE2 (glycerophosphodiester phosphodiesterase 2) inactivates RECK (reversion-inducing cysteine-rich protein with kazal motifs) by cleaving its GPI anchor, which results in the activation of Notch signaling during progression of neurogenesis (Muraguchi et al. 2007; Park et al. 2013) . ACE (angiotensin-converting enzyme) can cleave within the GPI moieties of various GPI-anchored proteins (Kondoh et al. 2005) . Thus, these none-metalloprotease GPI-cleavage enzymes might contribute to GM6001-insensitive release of polypeptides into the culture medium.
Exosomes are involved in neuronal differentiation (B atiz et al. 2015) , regeneration (Lopez-Verrilli et al. 2013; Chopp & Zhang 2015; de Rivero Vaccari et al. 2016 ) and other functions (Emmanouilidou et al. 2010; Lachenal et al. 2011; Korkut et al. 2013; Glebov et al. 2015) . To identify overall secreted glycoproteins during neural differentiation, we did not remove vesicular membranes from culture medium in this study, and thus, some of glycoproteins might be released as a component of exosomes or secretory vesicles. For example, transferrin receptor protein 1 (Johnstone et al. 1989; Harding et al. 2013 ) and ADAM10 (Stoeck et al. 2006; Shimoda et al. 2014) are incorporated into exosomes, and thus, GM6001 might affect their metalloprotease-dependent cleavages in exosomes. GM6001 might not only affect the ectodomain shedding in exosomes itself but also affect incorporation of glycoproteins into the exosomes. For example, inhibition of the shedding of ErbB ligands by GM6001 can result in decreased endocytosis and delivery of receptor molecules into exosomal compartments (Sanderson et al. 2008) .
In summary, we succeeded in the establishment of a sensitive and reliable method to systematically screen glycoproteins that are secreted from differentiating neurons in GM6001-sensitive manners using isotope tagging and enrichment of N-glycosylated peptides. The results indicate usefulness of this method in screening of glycoproteins shed proteolytically or those released by other secretory events. Our method is applicable for secretome analyses in various contexts using different cell types, different extracellular stimuli and different protease inhibitors. Such investigations should enormously expand our knowledge on the regulatory mechanisms of intercellular signaling and adhesion through the release of soluble glycoproteins.
Experimental procedures
Sample preparation for proteomics N1E-115 cells were cultured as described previously (Yokozeki et al. 2007 ). 1.8 9 10 6 N1E-115 cells were seeded into a single 10-cm-poly-lysine-coated dish 2 days before sample preparation, and cultured in fresh medium containing 2% fetal bovine serum for 12 h before sample preparation. Cells were washed with serum-free medium for three times and cultured in fresh serum-free DMEM with or without 50 lM GM6001 (Calbiochem) for 9 h. The conditioned media were collected and centrifuged at 15 000 g for 15 min to remove cell debris, and concentrated using Vivaspin (GE healthcare) up to~45-fold. Concentrated media were acidified by 50 mM acetate buffer (pH 5) and oxidized by 10 mM NaIO 4 for 30 min in the dark. Proteins were precipitated with methanol and chloroform and re-suspended in a buffer containing 8 M urea and 400 mM ammonium bicarbonate. Approximately 350 lg of proteins was obtained from 5.4 9 10 6 cells, and 300 lg of protein was reduced with 10 mM DTT, alkylated with 20 mM iodoacetamide and digested by trypsin (Promega). Digested peptides were purified using C18 column (Waters), concentrated, diluted with coupling buffer (Bio-Rad) and incubated with Affi-Gel Hydrazide Gel (Bio-Rad) at room temperature overnight. The gel was sequentially washed with 1.5 M NaCl, 80% acetonitrile, methanol and distilled water. (Hsu et al. 2003) and desalted with reversed phase-StageTip (Rappsilber et al. 2007 ).
LC-MS/MS
A self-pulled analytical column (ReproSil-Pur C18-AQ, 3 lm), HTC-PAL autosampler (CTC Analytics) and UltiMate 3000RSLCnano (Thermo Fisher SCIENTIFIC) were coupled to a Q Exactive mass spectrometer (Thermo Fisher SCIENTI-FIC). The injection volume was 5 lL, and the flow rate was 0.5 lL/min. The mobile phases consisted of (A) 0.5% acetic acid and (B) 0.5% acetic acid and 80% ACN. A three-step linear gradient (5À10% B in 5 min, 10À40% B in 60 min, 40À99% B in 5 min and 99% B for 10 min) was used. The scan range was m/z 350À1500, and the top ten precursor ions were selected in each MS scan for subsequent MS/MS scans. Dynamic exclusion time of 30 s was used. ProteoWizard (v.3.0.4449) and MaxQuant (v.1.5.1.2) were used to create peak lists. Peptides and proteins were identified by means of automated database searching using Mascot (Matrix Sciences; v.2.5.1) against UniprotKB/Swiss-Prot (2015_01) mouse (Mus musculus)-bovine (Bos taurus) manually concatenated database with a precursor mass tolerance of 5 ppm, a fragment ion mass tolerance of 0.02 Da, and strict trypsin specificity allowing for up to 2 missed cleavages. Cysteine carbamidomethylation was set as a fixed modification. C 2 ) dimethylation of amino groups at the peptide N-terminus and lysine were allowed as variable modifications. Peptides were considered identified if the Mascot score was over the 95% confidence limit (P < 0.05) for each peptide. False discovery rates (FDRs) were estimated by searching against a reversed decoy database. To reduce redundancy in protein identification, the identified peptides were reassigned to proteins based on a previously established protein inference concept (Nesvizhskii & Aebersold 2005) . Peptides were quantified based on the integrated peak areas, and the heavy-and lightlabeled peptide ratio (H/L ratio) was calculated.
Data processing
The raw data and analysis files have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexc hange.org) via the jPOST partner repository (http://jpost.org) with the data set identifier PXD004699 (JPST000055).
Informatics analysis
UniProtKB accession numbers of GM6001-sensitive proteins with >2-fold decrease were used for gene-annotation enrichment analysis by DAVID (v.6.8). All of quantified proteins were used as the background. From functional annotation charts, UniProtKB Keywords, the biological process class of Gene Ontology terms and the terms annotated by InterPro were listed in ascending order of P-value, with a gene count threshold ≥2.
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